#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fontan procedure Metabolic disorder Primary biliary cholangitis Advanced systemic mastocytosis B-cell lymphoma refractory Glomerulonephritis rapidly progressive Arterial tortuosity syndrome Facioscapulohumeral muscular dystrophy Plasma cell myeloma recurrent Philadelphia positive chronic myeloid leukaemia Oesophageal adenocarcinoma Leber's congenital amaurosis Prodromal Alzheimer's disease Noonan syndrome Pulmonary alveolar haemorrhage More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Treatment Acute respiratory distress syndrome – Treatment Testicular leiomyosarcoma Combined immunodeficiency Prolymphocytic leukaemia Inclusion body myositis – Diagnostics Glycogen storage disease type II – Diagnostics Alveolar rhabdomyosarcoma – Basic Information Prader-Willi syndrome – Treatment CADASIL – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xtmab-16 Betibeglogene Autotemcel Formoterol Fumarate Dihydrate Phenazone Enx-101 Mps-213 Pantothenate Sodium Azelastine AAV9-CTNT-COBAG3 7-Ethyl-10-Hydroxycamptothecin Milrinone Mk-1167 PALAZESTRANT Alrefimotide Carmustine L-Histidine Hydrochloride Dobutamine Hydrochloride 204-NETU Dorocubicel Topiramate More therapies…

    Learn about Your Condition

    Hypoaesthesia Cytokine release syndrome Neuroblastoma recurrent Pelizaeus-Merzbacher disease Immunodeficiency Neuropathic arthropathy Hypotransferrinaemia Tendon disorder Metabolic syndrome Partial seizures Prader-Willi syndrome Polycystic liver disease Testicular leiomyosarcoma Seasonal allergy Osteonecrosis of jaw More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Apixaban
    Finland

  • Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Rbd4059
    • Apixaban
    Denmark Norway Poland Sweden

  • Carboplatin drug combination as neoadjuvant therapy for early stage II triple‑negative breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Carboplatin
    • Cyclophosphamide Monohydrate
    France

  • Randomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome

    Not yet recruiting

    2 1
    Investigated Diseases:
    • VEXAS syndrome
    Italy

  • Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Crinecerfont
    Austria Bulgaria Czechia Germany Italy Portugal +3

  • Study of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenocarcinoma pancreas
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bms-986340
    • Nivolumab
    Italy
Previous Page
1 … 673 674 675 676 677 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!